← Back to Search

Behavioral Intervention

Digital Health Tool for Congenital Heart Disease (EmpowerMyCH Trial)

N/A
Waitlist Available
Led By Anushree Agarwal, MBBS, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with congenital heart disease
Aged 18 years or older
Must not have
Unable to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 6, 12, and 24 months
Awards & highlights

Summary

This trial aims to test a digital health tool called "Empower My Congenital Health" designed to help adults with congenital heart disease navigate the healthcare system with confidence. The tool includes features like

Who is the study for?
This trial is for adults with congenital heart disease (CHD) who are interested in using a digital tool to help manage their condition. The tool aims to empower patients by providing resources and community support.
What is being tested?
The 'Empower My Congenital Health' digital intervention is being tested for its ability to help CHD patients navigate the healthcare system, increase confidence, and improve health behaviors through features like a medical passport and patient stories.
What are the potential side effects?
Since this is a digital empowerment tool, traditional physical side effects are not applicable. However, users may experience increased screen time or stress if technical issues arise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was born with a heart condition.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to give consent by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 6, 12, and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 6, 12, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the intervention components
Feasibility of the intervention
Recruitment rate
+1 more
Secondary study objectives
Euro-Quality of Life
Gothenburg Empowerment Scale (GES)
Patient activation measure (PAM)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
This is a digital (web and mobile-based) multicomponent patient engagement behavioral intervention. The intervention components include digital medical passport, health-specific updated information, credible resources, connections with the community, peer- and expert support and guidance, among others

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,107 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,551 Previous Clinical Trials
15,257,786 Total Patients Enrolled
Anushree Agarwal, MBBS, MASPrincipal InvestigatorUniversity of California, San Francisco
~67 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top